| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| Cost of Revenue | $2.40B | +6.8% |
| Gross Profit | $129.8M | +48.8% |
| R&D Expense | $80.5M | -10.5% |
| SG&A Expense | $199.5M | -12.2% |
| Operating Income | -$105.0M | +49.8% |
| Pre-tax Income | -$200.5M | +30.7% |
| Income Tax | $17.3M | -56.1% |
| Net Income | -$215.4M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $186.9M | -24.7% |
| Accounts Receivable | $358.7M | +13.0% |
| Inventory | $157.8M | -0.2% |
| Current Assets | $945.6M | -5.0% |
| Total Assets | $1.96B | -11.8% |
| Current Liabilities | $631.6M | +5.7% |
| Long-term Debt | $982.1M | +0.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$36.1M | +68.7% |
| Investing Cash Flow | -$17.9M | +80.4% |
| Financing Cash Flow | -$4.3M | -232.9% |
| +33.3% |
| EPS (Basic) | -$12.53 | +33.8% |
| EPS (Diluted) | -$12.53 | +33.8% |
| Total Liabilities |
| $1.86B |
| -1.7% |
| Stockholders' Equity | $107.7M | -66.8% |